Success Metrics

Active Trials
2(25%)

Phase Distribution

Ph phase_2
1
13%
Ph phase_1
7
88%

Phase Distribution

7

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
7(87.5%)
Phase 2Efficacy & side effects
1(12.5%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

8

all time

Status Distribution
Active(8)

Detailed Status

Not yet recruiting6
Recruiting2

Development Timeline

Analytics

Development Status

Total Trials
8
Active
2
Success Rate
N/A
Most Advanced
Phase 2

Trials by Phase

Phase 17 (87.5%)
Phase 21 (12.5%)

Trials by Status

recruiting225%
not_yet_recruiting675%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
DRUG
Total Trials
8